Global Genomics Biomarkers Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12249360

Publication Date:

December 13, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Genomics Biomarkers market size was valued at US$ million in 2023. With growing demand in downstream market, the Genomics Biomarkers is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Genomics Biomarkers market. Genomics Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Genomics Biomarkers. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Genomics Biomarkers market.
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
Key Features:
The report on Genomics Biomarkers market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Genomics Biomarkers market. It may include historical data, market segmentation by Type (e.g., Oncology, Cardiovascular Diseases), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Genomics Biomarkers market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Genomics Biomarkers market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Genomics Biomarkers industry. This include advancements in Genomics Biomarkers technology, Genomics Biomarkers new entrants, Genomics Biomarkers new investment, and other innovations that are shaping the future of Genomics Biomarkers.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Genomics Biomarkers market. It includes factors influencing customer ' purchasing decisions, preferences for Genomics Biomarkers product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Genomics Biomarkers market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Genomics Biomarkers market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Genomics Biomarkers market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Genomics Biomarkers industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Genomics Biomarkers market.
Market Segmentation:
Genomics Biomarkers market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Oncology
Cardiovascular Diseases
Neurological Diseases
Segmentation by application
Diagnostic and Research Laboratories
Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genomics Biomarkers Market Size 2019-2030
2.1.2 Genomics Biomarkers Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Genomics Biomarkers Segment by Type
2.2.1 Oncology
2.2.2 Cardiovascular Diseases
2.2.3 Neurological Diseases
2.3 Genomics Biomarkers Market Size by Type
2.3.1 Genomics Biomarkers Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Genomics Biomarkers Market Size Market Share by Type (2019-2024)
2.4 Genomics Biomarkers Segment by Application
2.4.1 Diagnostic and Research Laboratories
2.4.2 Hospitals
2.5 Genomics Biomarkers Market Size by Application
2.5.1 Genomics Biomarkers Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Genomics Biomarkers Market Size Market Share by Application (2019-2024)
3 Genomics Biomarkers Market Size by Player
3.1 Genomics Biomarkers Market Size Market Share by Players
3.1.1 Global Genomics Biomarkers Revenue by Players (2019-2024)
3.1.2 Global Genomics Biomarkers Revenue Market Share by Players (2019-2024)
3.2 Global Genomics Biomarkers Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genomics Biomarkers by Regions
4.1 Genomics Biomarkers Market Size by Regions (2019-2024)
4.2 Americas Genomics Biomarkers Market Size Growth (2019-2024)
4.3 APAC Genomics Biomarkers Market Size Growth (2019-2024)
4.4 Europe Genomics Biomarkers Market Size Growth (2019-2024)
4.5 Middle East & Africa Genomics Biomarkers Market Size Growth (2019-2024)
5 Americas
5.1 Americas Genomics Biomarkers Market Size by Country (2019-2024)
5.2 Americas Genomics Biomarkers Market Size by Type (2019-2024)
5.3 Americas Genomics Biomarkers Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genomics Biomarkers Market Size by Region (2019-2024)
6.2 APAC Genomics Biomarkers Market Size by Type (2019-2024)
6.3 APAC Genomics Biomarkers Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genomics Biomarkers by Country (2019-2024)
7.2 Europe Genomics Biomarkers Market Size by Type (2019-2024)
7.3 Europe Genomics Biomarkers Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genomics Biomarkers by Region (2019-2024)
8.2 Middle East & Africa Genomics Biomarkers Market Size by Type (2019-2024)
8.3 Middle East & Africa Genomics Biomarkers Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Genomics Biomarkers Market Forecast
10.1 Global Genomics Biomarkers Forecast by Regions (2025-2030)
10.1.1 Global Genomics Biomarkers Forecast by Regions (2025-2030)
10.1.2 Americas Genomics Biomarkers Forecast
10.1.3 APAC Genomics Biomarkers Forecast
10.1.4 Europe Genomics Biomarkers Forecast
10.1.5 Middle East & Africa Genomics Biomarkers Forecast
10.2 Americas Genomics Biomarkers Forecast by Country (2025-2030)
10.2.1 United States Genomics Biomarkers Market Forecast
10.2.2 Canada Genomics Biomarkers Market Forecast
10.2.3 Mexico Genomics Biomarkers Market Forecast
10.2.4 Brazil Genomics Biomarkers Market Forecast
10.3 APAC Genomics Biomarkers Forecast by Region (2025-2030)
10.3.1 China Genomics Biomarkers Market Forecast
10.3.2 Japan Genomics Biomarkers Market Forecast
10.3.3 Korea Genomics Biomarkers Market Forecast
10.3.4 Southeast Asia Genomics Biomarkers Market Forecast
10.3.5 India Genomics Biomarkers Market Forecast
10.3.6 Australia Genomics Biomarkers Market Forecast
10.4 Europe Genomics Biomarkers Forecast by Country (2025-2030)
10.4.1 Germany Genomics Biomarkers Market Forecast
10.4.2 France Genomics Biomarkers Market Forecast
10.4.3 UK Genomics Biomarkers Market Forecast
10.4.4 Italy Genomics Biomarkers Market Forecast
10.4.5 Russia Genomics Biomarkers Market Forecast
10.5 Middle East & Africa Genomics Biomarkers Forecast by Region (2025-2030)
10.5.1 Egypt Genomics Biomarkers Market Forecast
10.5.2 South Africa Genomics Biomarkers Market Forecast
10.5.3 Israel Genomics Biomarkers Market Forecast
10.5.4 Turkey Genomics Biomarkers Market Forecast
10.5.5 GCC Countries Genomics Biomarkers Market Forecast
10.6 Global Genomics Biomarkers Forecast by Type (2025-2030)
10.7 Global Genomics Biomarkers Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Information
11.1.2 Roche Diagnostics Genomics Biomarkers Product Offered
11.1.3 Roche Diagnostics Genomics Biomarkers Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Diagnostics Main Business Overview
11.1.5 Roche Diagnostics Latest Developments
11.2 Myriad Genetics
11.2.1 Myriad Genetics Company Information
11.2.2 Myriad Genetics Genomics Biomarkers Product Offered
11.2.3 Myriad Genetics Genomics Biomarkers Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Myriad Genetics Main Business Overview
11.2.5 Myriad Genetics Latest Developments
11.3 QIAGEN
11.3.1 QIAGEN Company Information
11.3.2 QIAGEN Genomics Biomarkers Product Offered
11.3.3 QIAGEN Genomics Biomarkers Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 QIAGEN Main Business Overview
11.3.5 QIAGEN Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Genomics Biomarkers Product Offered
11.4.3 Thermo Fisher Scientific Genomics Biomarkers Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Information
11.5.2 Bio-Rad Laboratories Genomics Biomarkers Product Offered
11.5.3 Bio-Rad Laboratories Genomics Biomarkers Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bio-Rad Laboratories Main Business Overview
11.5.5 Bio-Rad Laboratories Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂